1-4 of 4
Isabel Taubert
Close
Sort by
Journal Articles

Frequency of Leukemia Stem Cell Candidates Predicts Refractoriness to Conventional Chemotherapy and Adverse Clinical Outcome

Dan Ran, MD, Isabel Taubert, Volker Eckstein, PhD, Frauke Bellos, MD, Patrick Wuchter, MD, Rainer Saffrich, PhD, Mario Schubert, MD, Anthony D. Ho, MD, FRCPC
Journal: Blood
Blood (2010) 116 (21): 2160.
https://doi.org/10.1182/blood.V116.21.2160.2160
Published: 2010
Journal Articles

Comparative in-Vitro Evaluation of the Myeloid Toxicity of Pentostatin and the Novel PNP-Inhibitor Forodesine.

Mario Schubert, MD, Christian Wallenwein, Larissa Pietsch, Dan Ran, Isabel Taubert, Katrin Miesala, Patrick Wuchter, MD, Volker Eckstein, PhD, Anthony D. Ho, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3766.
https://doi.org/10.1182/blood.V114.22.3766.3766
Published: 2009
Journal Articles

Molecular Determinants and Functional Characteristics of Leukemic Stem Cells and Their Interaction with the Niche.

Dan Ran, Isabel Taubert, Larissa Pietsch, Patrick Wuchter, MD, Isabelle Hellwig, Rainer Saffrich, PhD, Volker Eckstein, PhD, Anthony D. Ho, MD, PhD and, Mario Schubert, MD
Journal: Blood
Blood (2009) 114 (22): 1427.
https://doi.org/10.1182/blood.V114.22.1427.1427
Published: 2009
Journal Articles

Increased Aldehyde Dehydrogenase Activity Indentifies a Subset of Human Leukemic Blasts with Stem Cell Characteristics and Correlates with Poor Prognosis.

Dan Ran, Mario Schubert, MD, Larissa Pietsch, Isabel Taubert, Christian Wallenwein, Katrin Miesala, Kerstin Woerner, Patrick Wuchter, MD, Volker Eckstein, PhD, Tom Bruckner, PhD, Anthony Ho, MD
Journal: Blood
Blood (2008) 112 (11): 1345.
https://doi.org/10.1182/blood.V112.11.1345.1345
Published: 2008